Suk Han Wan

1.0k total citations
22 papers, 819 citations indexed

About

Suk Han Wan is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Pharmacology. According to data from OpenAlex, Suk Han Wan has authored 22 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pediatrics, Perinatology and Child Health, 4 papers in Pharmacology and 3 papers in Pharmacology. Recurrent topics in Suk Han Wan's work include Analytical Chemistry and Chromatography (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Suk Han Wan is often cited by papers focused on Analytical Chemistry and Chromatography (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Suk Han Wan collaborates with scholars based in United States and Poland. Suk Han Wan's co-authors include Daniel L. Azarnoff, David H. Huffman, Shaikh B. Matin, Barth Hoogstraten, John H. Karam, Sidney Riegelman, Robert F. Maronde, Pertti J. Pentikäinen, William E. Larsen and James B. Knight and has published in prestigious journals such as Journal of Chromatography A, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Suk Han Wan

22 papers receiving 725 citations

Peers

Suk Han Wan

PHEOH

ONCOL

PPCH

PHARM

J.P. Desager Belgium

David H. Huffman United States

Peter Seideman Sweden

Jean‐Paul Cano France

Katharine J. Palmer New Zealand

Phillip A. Reece Australia

Preben Jakobsen Denmark

J. P. Cano France

Gilbert N. Lam United States

Arne Hanson Sweden

J.P. Desager Belgium

Suk Han Wan

252 ×1.3

PHEOH

122 ×0.9

ONCOL

129 ×1.0

PPCH

130 ×1.0

121 ×1.0

PHARM

Citations per year, relative to Suk Han Wan Suk Han Wan (= 1×) peers J.P. Desager

Countries citing papers authored by Suk Han Wan

Since Specialization

Citations

This map shows the geographic impact of Suk Han Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suk Han Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suk Han Wan more than expected).

Fields of papers citing papers by Suk Han Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suk Han Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suk Han Wan. The network helps show where Suk Han Wan may publish in the future.

Co-authorship network of co-authors of Suk Han Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Suk Han Wan. A scholar is included among the top collaborators of Suk Han Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suk Han Wan. Suk Han Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wan, Suk Han, et al.. (1982). Pharmacokinetics and Metabolism of Naproxen inChildren. Developmental Pharmacology and Therapeutics. 5(3-4). 143–150. 15 indexed citations

Velasquez, Manuel T., Suk Han Wan, John W. Barr, & Robert F. Maronde. (1981). Effect of Probenecid on the Natriuresis and Renin Release Induced by Bumetanide in Man. The Journal of Clinical Pharmacology. 21(11). 657–662. 7 indexed citations

Wan, Suk Han, et al.. (1979). Clinical Evaluation of the EMIT® Procainamide and N-Acetylprocainamide Assay. Therapeutic Drug Monitoring. 1(1). 47–56. 4 indexed citations

Nayar, M. S. B., et al.. (1979). Gas Chromatographic Analysis of Cyclophosphamide in Plasma and Tissues Using Nitrogen-Phosphorus Detection. Analytical Letters. 12(8). 905–915. 8 indexed citations

Wan, Suk Han & Shaikh B. Matin. (1979). Quantitative gas-liquid chromatographic analysis of naproxen, 6-O-desmethyl-naproxen and their conjugates in urine. Journal of Chromatography A. 170(2). 473–478. 23 indexed citations

Velasquez, Manuel T., Suk Han Wan, & Robert F. Maronde. (1979). Effects of metoprolol on blood pressure and plasma renin activity in thiazide‐resistant hypertensive patients. Clinical Pharmacology & Therapeutics. 26(5). 555–561. 4 indexed citations

Wan, Suk Han, Shaikh B. Matin, & Daniel L. Azarnoff. (1978). Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH. Clinical Pharmacology & Therapeutics. 23(5). 585–590. 81 indexed citations

Wan, Suk Han, Robert F. Maronde, & Shaikh B. Matin. (1978). GLC Determination of Atenolol and β-Blocking Agents in Biological Fluids. Journal of Pharmaceutical Sciences. 67(9). 1340–1342. 27 indexed citations

Matin, Shaikh B., Suk Han Wan, & James B. Knight. (1977). Quantitative determination of enantiomeric compounds. I—simultaneous measurement of the optical isomers of amphetamine in human plasma and saliva using chemical ionization mass spectrometry. Journal of Mass Spectrometry. 4(2). 118–121. 31 indexed citations

10.

Wan, Suk Han, Pertti J. Pentikäinen, & Daniel L. Azarnoff. (1974). Bioavailability of Aminosalicylic Acid and Its Various Salts in Humans III: Absorption from Tablets. Journal of Pharmaceutical Sciences. 63(5). 708–711. 21 indexed citations

11.

Wan, Suk Han, Pertti J. Pentikäinen, & Daniel L. Azarnoff. (1974). Bioavailability studies on para-aminosalicylic acid and its various salts in man. I. Absorption from solution and suspension. Journal of Pharmacokinetics and Biopharmaceutics. 2(1). 1–12. 13 indexed citations

12.

Matin, Shaikh B., Suk Han Wan, & John H. Karam. (1974). Pharmacokinetics of tolbutamide: Prediction by concentration in saliva. Clinical Pharmacology & Therapeutics. 16(6). 1052–1058. 111 indexed citations

13.

Pentikäinen, Pertti J., Daniel L. Azarnoff, & Suk Han Wan. (1974). Bioavailability of Aminosalicylic Acid and its Various Salts in Humans IV: Comparison of Four Brands of the Sodium Salt. Journal of Pharmaceutical Sciences. 63(9). 1431–1434. 6 indexed citations

14.

Wan, Suk Han, et al.. (1974). Effect of route of administration and effusions on methotrexate pharmacokinetics.. PubMed. 34(12). 3487–91. 94 indexed citations

15.

Wan, Suk Han, David H. Huffman, Daniel L. Azarnoff, Barth Hoogstraten, & William E. Larsen. (1974). Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine in humans.. PubMed. 34(2). 392–7. 50 indexed citations

16.

Azarnoff, Daniel L., Suk Han Wan, & David H. Huffman. (1974). Pharmacokinetics of methotrexate. Clinical Pharmacology & Therapeutics. 16(5part2). 884–885. 132 indexed citations

17.

Huffman, David H., Suk Han Wan, Daniel L. Azarnoff, & Barth Hoogstraten. (1973). Pharmacokinetics of methotrexate. Clinical Pharmacology & Therapeutics. 14(4part1). 572–579. 99 indexed citations

18.

Wan, Suk Han, et al.. (1972). Renal Contribution to Overall Metabolism of Drugs III: Metabolism of p-Aminobenzoic Acid. Journal of Pharmaceutical Sciences. 61(8). 1288–1292. 19 indexed citations

19.

Kauffman, Ralph E., Don W. Shoeman, Suk Han Wan, & Daniel L. Azarnoff. (1972). Absorption and excretion of clindamycin‐2‐phosphate in children after intramuscular injection. Clinical Pharmacology & Therapeutics. 13(5part1). 704–709. 11 indexed citations

20.

Wan, Suk Han & Sidney Riegelman. (1972). Renal Contribution to Overall Metabolism of Drugs II: Biotransformation of Salicylic Acid to Salicyluric Acid. Journal of Pharmaceutical Sciences. 61(8). 1284–1287. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact